FDA v. Wages and White Lion Investments, LLC | Date Decided: 4/2/25 | Case No. 23-1038
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
FDA v. Wages and White Lion Investments, LLC | Date Decided: 4/2/25 | Case No. 23-1038
-
Narrated by:
-
By:
About this listen
The question presented in this case is: Whether the court of appeals erred in setting aside FDA's denial orders as arbitrary and capricious.
The Supreme Court held: The Fifth Circuit’s conclusion that the FDA acted arbitrarily and capriciously in its adjudication of manufacturers’ premarket tobacco product applications is vacated because the FDA’s denial orders were sufficiently consistent with its predecisional guidance—as to scientific evidence, comparative efficacy, and device type—and thus did not run afoul of the change-in-position doctrine.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.